Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e1802 (Published 27 March 2012)
Cite this as: BMJ 2012;344:e1802

Related articles

Research: Health related quality of life after combined hormone replacement therapy: randomised controlled trial

Research: A meta-analysis of the association between adherence to drug therapy and mortality

RESEARCH: A meta-analysis of the association between adherence to drug therapy and mortality

See more

News: Americans should lower salt intake but not too much, review says

News: Autopsies using MRIs in babies and infants could help improve uptake rates

News: Challenge to research on heart disease patterns in India sparks controversy

Research News: No cardiovascular benefit from fish oil for high risk adults

Research News: Uninterrupted anticoagulation during pacemaker or defibrillator surgery

This article has been cited by other articles:

THIS WEEK'S POLL